Annals of the Rheumatic Diseases: 82 (4)

Review

Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis (5 December, 2022)
Lucy R Wedderburn, Athimalaipet V Ramanan, Adam P Croft, Kimme L Hyrich, Andrew D Dick

Views on news

Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management? (28 November, 2022)
Nathalie Conrad, Iain B McInnes, John J V Mcmurray, Naveed Sattar

Rheumatoid arthritis

Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial (21 December, 2022)
Renske CF Hebing, Marry Lin, Maja Bulatovic Calasan, Ittai B Muller, Sohaila Mahmoud, Sandra Heil, Eduard A Struys, Bart JF van den Bemt, Jos WR Twisk, Willem Lems, Michael T Nurmohamed, Gerrit Jansen, Robert de Jonge
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis (16 December, 2022)
Lotte van Ouwerkerk, Maarten Boers, Paul Emery, Pascal HP de Jong, Robert BM Landewé, Willem Lems, Josef S Smolen, Patrick Verschueren, Tom WJ Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis (10 January, 2023)
Andreas Kerschbaumer, Nina Maria Stimakovits, Josef S Smolen, Tijen Stefanova, Eva Chwala, Daniel Aletaha
Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells (2 January, 2023)
Anja Meyer, Ryan E Sienes, Wes Nijim, Brian Zanotti, Sadiq Umar, Michael V Volin, Katrien Van Raemdonck, Myles Lewis, Costantino Pitzalis, Shiva Arami, Mina Al-Awqati, Huan J Chang, Pim Jetanalin, Georg Schett, Nadera Sweiss, Shiva Shahrara

Psoriatic arthritis

Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study (13 December, 2022)
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Mohamed Sharaf, Elke Theander, Josef S Smolen
Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin (12 December, 2022)
Alba Boix-Amorós, Michelle H Badri, Julia Manasson, Rebecca B Blank, Rebecca H Haberman, Andrea L Neimann, Parvathy V Girija, Anthony Jimenez Hernandez, Adriana Heguy, Sergei B Koralov, Richard Bonneau, Jose C Clemente, Jose U Scher

Spondyloarthritis

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials (17 January, 2023)
Désirée van der Heijde, Atul Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip Van den Bosch, Thomas Vaux, Huji Xu
Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis (21 December, 2022)
Bora Nam, Sungsin Jo, So-Young Bang, Youngho Park, Ji Hui Shin, Ye-Soo Park, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim
Piezo1-mediated mechanotransduction promotes entheseal pathological new bone formation in ankylosing spondylitis (21 December, 2022)
Siwen Chen, Zihao Li, Dongying Chen, Haowen Cui, Jianru Wang, Zemin Li, Xiang Li, Zhaomin Zheng, Zhongping Zhan, Hui Liu

Myositis

Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies (26 December, 2022)
Jean-Baptiste Vulsteke, Rita Derua, Sylvain Dubucquoi, Frédéric Coutant, Sebastien Sanges, David Goncalves, Greet Wuyts, Petra De Haes, Daniel Blockmans, Wim A Wuyts, Kristl G Claeys, Ellen De Langhe, Nicole Fabien, Xavier Bossuyt

Vasculitis

The provisional OMERACT ultrasonography score for giant cell arteritis (12 December, 2022)
Christian Dejaco, Cristina Ponte, Sara Monti, Davide Rozza, Carlo Alberto Scirè, Lene Terslev, George A W Bruyn, Dennis Boumans, Wolfgang Hartung, Alojzija Hočevar, Marcin Milchert, Uffe Møller Døhn, Chetan B Mukhtyar, Markus Aschwanden, Philipp Bosch, Dario Camellino, Stavros Chrysidis, Giovanni Ciancio, Maria Antonietta D’Agostino, Thomas Daikeler, Bhaskar Dasgupta, Eugenio De Miguel, Andreas P Diamantopoulos, Christina Duftner, Ana Agueda, Ulrich Fredberg, Petra Hanova, Ib Tønder Hansen, Ellen-Margrethe Hauge, Annamaria Iagnocco, Nevsun Inanc, Aaron Juche, Rositsa Karalilova, Toshio Kawamoto, Kresten Krarup Keller, Helen Isobel Keen, Tanaz A Kermani, Minna J. Kohler, Matthew Koster, Raashid Ahmed Luqmani, Pierluigi Macchioni, Sarah Louise Mackie, Esperanza Naredo, Berit Dalsgaard Nielsen, Michihiro Ogasawara, Carlos Pineda, Valentin Sebastian Schäfer, Luca Seitz, Alessandro Tomelleri, Karina D Torralba, Kornelis S M van der Geest, Kenneth J Warrington, Wolfgang A Schmidt

Epidemiology

Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases (28 November, 2022) Free
Naomi J Patel, Claire Cook, Kathleen Vanni, Xiaoqing Fu, Xiaosong Wang, Yumeko Kawano, Grace Qian, Buuthien Hang, Shruthi Srivatsan, Emily P Banasiak, Emily Kowalski, Katarina Bade, Yuqing Zhang, Jeffrey A Sparks, Zachary S. Wallace

Letters

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme (31 January, 2023)
Maxime Dougados, Christina Charles-Schoeman, Zoltán Szekanecz, Jon T Giles, Steven R Ytterberg, Deepak L Bhatt, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Carol A Connell, Arne Yndestad, Jose L Rivas, Maya H Buch
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero (5 January, 2023)
Helle Bitter, David John Warren, Nils Bolstad, Anne LIndtner Noraas, Monika Elisabeth Ostensen
Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy (6 January, 2023)
Océane Landon-Cardinal, Hugues Allard-Chamard, Hugo Chapdelaine, Stéphane Doucet, Éric Rich, Josiane Bourré-Tessier
Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality? (20 December, 2022)
Marcus von Deimling, Thomas C Koehler, Bjoern Christian Frye, Elisabeth Maerker-Hermann, Nils Venhoff

Thank you to our reviewers

Thank you to our reviewers 2022 (10 March, 2023) Free

Electronic pages

Correspondence on ‘Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome’ (27 January, 2021)
Tomoyuki Kawada
Response to: ‘Correspondence on ‘Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome’’ by Kawada (27 January, 2021)
Silvia Piantoni, Laura Andreoli, Enrico Colombo, Monia Mendeni, Maria Laura Ghirardelli, Antonio Brucato, Massimo Imazio, Roberto Furloni, Franco Franceschini, Paolo Airó, Mirko Scarsi
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’ (15 January, 2021)
Haiyan Yang, Jie Xu, Li Shi, Guangcai Duan, Yadong Wang
Response to: ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Yang et al
(15 January, 2021)
Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba
Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’ (28 January, 2021)
Carlo Perricone, Elena Bartoloni, Giacomo Cafaro, Roberto Caporali, Roberto Gerli
Response to: ‘Correspondence on ‘Anti-inflammatory therapy for COVID-19 infection: the case for colchicine’’ by Perricone et al
(28 January, 2021)
Binita Shah, Aaron Z Reyes, Kelly A Hu, Jacob Teperman, Theresa L Wampler Muskardin, Jean-Claude Tardif, Michael H Pillinger
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’ (27 January, 2021)
Young Ho Lee
Response to: ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Lee (27 January, 2021)
Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba
Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia? (24 July, 2020)
Emine Duran, Levent Kilic, Gamze Durhan, Ahmet Çağkan Inkaya, Gulay Sain Guven, Gul Karakaya, Orhan Macit Ariyurek, Omer Karadag
Transient monoarthritis and psoriatic skin lesions following COVID-19 (4 August, 2020)
Ludovico De Stefano, Silvia Rossi, Carlomaurizio Montecucco, Serena Bugatti
Correspondence on ‘Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden’ (1 February, 2021) Free
Maria I Zervou, George N Goulielmos
Response to: ‘Correspondence on ‘Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden’’ by Zervou et al
(1 February, 2021) Free
Viktor Molander, Johan Askling
Correspondence on ‘Cardiovascular effects of biological versus csDMARD therapy in treatment naive, early rheumatoid arthritis’ (8 February, 2021) Free
Athanasios N Georgiadis, Eleftherios Pelechas, Paraskevi V Voulgari, Alexandros A Drosos
Response to: ‘Correspondence on ‘Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis’’ by Georgiadis et al
(8 February, 2021) Free
Sven Plein, Maya H Buch
Correspondence on ‘Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis’ (16 February, 2021) Free
Katja Reuter, Elena Rocca
Response to ‘Correspondence on ‘Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis’’ by Reuter et al
(16 February, 2021) Free
Chanakya Sharma, Samuel Whittle, Pari Delir Haghighi, Frada Burstein, Helen Isobel Keen
Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’ (8 February, 2021) Free
Bing-kun Zheng
Response to: ‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’’ by Zheng (8 February, 2021) Free
Shahab Abtahi, Johanna H M Driessen, Andrea M Burden, Patrick C Souverein, Joop P van den Bergh, Tjeerd P van Staa, Annelies Boonen, Frank de Vries
Correspondence on ‘Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study’ (11 December, 2020) Free
Julien Maquet, Margaux Lafaurie, Laurent Sailler, Maryse Lapeyre-Mestre, Guillaume Moulis
Response to: ‘Correspondence on ‘Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study’’ by Maquet et al
(11 December, 2020) Free
Xiao-Huan Chen, James Cheng Chung Wei, Han-You Mo, Hsin-Hua Chen
Response to: ‘Correspondence on ‘Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study’’ by Maquet et al
(13 January, 2021) Free
Xiao-Huan Chen, Fang-Xiao Zhu, Hsin-Hua Chen, James Cheng-Chung Wei
Correspondence on ‘Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study’ (6 January, 2021) Free
Tsung-Kun Lin, Lung-Fa Pan, Gwo-Ping Jong
Response to: ‘Correspondence on ‘Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study’’ by Lin et al
(6 January, 2021) Free
Chao Zeng, Zidan Yang, Guanghua Lei, Yuqing Zhang
Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’ (25 January, 2021) Free
Jun Zou, Chen-Hong Lin, Yan Wang, Yan Shen, Jian-Long Guan
Response to: ‘Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’’ by Zou et al
(25 January, 2021) Free
Jinjing Liu, Chan Zhao, Wenjie Zheng
Correspondence on ‘Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation’ (3 February, 2021) Free
Pietro Randelli, Lavinia Agra Coletto, Alessandra Menon, Roberto Caporali
Response to: ‘Correspondence on ‘Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitation’’ by Randelli et al
(3 February, 2021) Free
Sanna Cederqvist, Tapio Flinkkilä, Jari Ylinen, Hannu Kautiainen, Antti Tuominen, Ilkka Kiviranta, Juha Paloneva

Main menu

Table of contents

April 2023 - Volume 82 - 4

Review

Views on news

Rheumatoid arthritis

Psoriatic arthritis

Spondyloarthritis

Myositis

Vasculitis

Epidemiology

Letters

Thank you to our reviewers

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

April 2023 - Volume 82 - 4

Review

Views on news

Rheumatoid arthritis

Psoriatic arthritis

Spondyloarthritis

Myositis

Vasculitis

Epidemiology

Letters

Thank you to our reviewers

Electronic pages

Issue Information